Investment Summary |
|
|---|---|
| Date | 2020-07-08 |
| Target | Xilis |
| Sector | Life Science |
| Investor(s) | EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 47 |
| Sector: Life Science M&A | 17 of 30 |
| Type: Venture M&A Deals | 25 of 39 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 6 of 11 |
| Year: 2020 M&A | 6 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-08 |
VarmX
Leiden, Netherlands VarmX is a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation. VarmX was founded in 2016 and is based in Leiden, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-09 |
VICO Therapeutics
Leiden, Netherlands Vico Therapeutics is developing therapies for rare neurological diseases, leveraging RNA modifying technologies. VICO Therapeutics was founded in 2019 and is based in Leiden, Netherlands. |
Buy | - |
